AURA
Price
$7.77
Change
+$0.10 (+1.30%)
Updated
Jan 17, 04:59 PM (EDT)
Capitalization
383.13M
54 days until earnings call
MGTX
Price
$6.27
Change
+$0.34 (+5.73%)
Updated
Jan 17, 04:59 PM (EDT)
Capitalization
463.45M
54 days until earnings call
Ad is loading...

AURA vs MGTX

Header iconAURA vs MGTX Comparison
Open Charts AURA vs MGTXBanner chart's image
Aura Biosciences
Price$7.77
Change+$0.10 (+1.30%)
Volume$1.5K
Capitalization383.13M
MeiraGTx Holdings
Price$6.27
Change+$0.34 (+5.73%)
Volume$7.29K
Capitalization463.45M
AURA vs MGTX Comparison Chart
Loading...
AURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AURA vs. MGTX commentary
Jan 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AURA is a Hold and MGTX is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 18, 2025
Stock price -- (AURA: $7.67 vs. MGTX: $5.93)
Brand notoriety: AURA and MGTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AURA: 60% vs. MGTX: 104%
Market capitalization -- AURA: $383.13M vs. MGTX: $463.45M
AURA [@Biotechnology] is valued at $383.13M. MGTX’s [@Biotechnology] market capitalization is $463.45M. The market cap for tickers in the [@Biotechnology] industry ranges from $370.67B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AURA’s FA Score shows that 1 FA rating(s) are green whileMGTX’s FA Score has 0 green FA rating(s).

  • AURA’s FA Score: 1 green, 4 red.
  • MGTX’s FA Score: 0 green, 5 red.
According to our system of comparison, AURA is a better buy in the long-term than MGTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AURA’s TA Score shows that 4 TA indicator(s) are bullish while MGTX’s TA Score has 3 bullish TA indicator(s).

  • AURA’s TA Score: 4 bullish, 4 bearish.
  • MGTX’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, AURA is a better buy in the short-term than MGTX.

Price Growth

AURA (@Biotechnology) experienced а -2.91% price change this week, while MGTX (@Biotechnology) price change was -6.61% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.05%. For the same industry, the average monthly price growth was +3.04%, and the average quarterly price growth was -1.59%.

Reported Earning Dates

AURA is expected to report earnings on May 08, 2025.

MGTX is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (-1.05% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MGTX($463M) has a higher market cap than AURA($383M). MGTX YTD gains are higher at: -2.627 vs. AURA (-6.691). MGTX has higher annual earnings (EBITDA): -61.2M vs. AURA (-91.84M). AURA has more cash in the bank: 174M vs. MGTX (123M). AURA has less debt than MGTX: AURA (19.1M) vs MGTX (86.7M). MGTX has higher revenues than AURA: MGTX (13.9M) vs AURA (0).
AURAMGTXAURA / MGTX
Capitalization383M463M83%
EBITDA-91.84M-61.2M150%
Gain YTD-6.691-2.627255%
P/E RatioN/AN/A-
Revenue013.9M-
Total Cash174M123M141%
Total Debt19.1M86.7M22%
FUNDAMENTALS RATINGS
MGTX: Fundamental Ratings
MGTX
OUTLOOK RATING
1..100
76
VALUATION
overvalued / fair valued / undervalued
1..100
56
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
54
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AURAMGTX
RSI
ODDS (%)
Bullish Trend 4 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 4 days ago
81%
Momentum
ODDS (%)
Bearish Trend 4 days ago
82%
Bearish Trend 4 days ago
84%
MACD
ODDS (%)
Bearish Trend 4 days ago
83%
Bearish Trend 4 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
84%
Bearish Trend 4 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
84%
Bearish Trend 4 days ago
83%
Advances
ODDS (%)
Bullish Trend 15 days ago
78%
Bullish Trend 15 days ago
81%
Declines
ODDS (%)
Bearish Trend 5 days ago
83%
Bearish Trend 4 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
76%
Bullish Trend 4 days ago
79%
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
83%
View a ticker or compare two or three
Ad is loading...
AURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SPY591.64-1.14
-0.19%
SPDR® S&P 500® ETF Trust
BTC.X99756.910000-747.585940
-0.74%
Bitcoin cryptocurrency
GME27.72-0.24
-0.86%
GameStop Corp
TSLA413.82-14.40
-3.36%
Tesla
AAPL228.26-9.61
-4.04%
Apple

AURA and

Correlation & Price change

A.I.dvisor indicates that over the last year, AURA has been loosely correlated with ABCL. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if AURA jumps, then ABCL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AURA
1D Price
Change %
AURA100%
-0.78%
ABCL - AURA
54%
Loosely correlated
-0.68%
MGTX - AURA
50%
Loosely correlated
+3.85%
EDIT - AURA
49%
Loosely correlated
+1.64%
ABOS - AURA
48%
Loosely correlated
-5.85%
VRDN - AURA
47%
Loosely correlated
-1.90%
More

MGTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MGTX has been loosely correlated with BEAM. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if MGTX jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MGTX
1D Price
Change %
MGTX100%
+3.85%
BEAM - MGTX
54%
Loosely correlated
+0.04%
NTLA - MGTX
54%
Loosely correlated
-2.99%
ABOS - MGTX
51%
Loosely correlated
-5.85%
AURA - MGTX
50%
Loosely correlated
-0.78%
EDIT - MGTX
50%
Loosely correlated
+1.64%
More